TERT and non-small cell lung carcinoma: Amplification of TERT may be a marker for poorer prognosis in early-stage NSCLC [9] and Liu et al. demonstrated prognostic significance for TERT CNV, showing that TERT was associated with a 35% risk reduction of LUAD progression [23].